Hamilton, NJ, United States of America

Hugh Alfred Burgoon, Jr


 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Hugh Alfred Burgoon, Jr: Innovator in Pharmaceutical Chemistry

Introduction

Hugh Alfred Burgoon, Jr. is a notable inventor based in Hamilton, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work primarily focuses on the development of innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Burgoon has developed methods for preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds. These methods are useful for creating compounds of formula I and their salts. Additionally, he has disclosed intermediates that are essential in the preparation of such compounds. Another significant area of his research involves compounds useful in the preparation of tryptophan hydroxylase inhibitors, where he has outlined intermediates and synthetic processes for substituted phenylalanine-based compounds.

Career Highlights

Hugh Alfred Burgoon, Jr. is currently employed at Lexicon Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical innovation. His expertise in synthetic chemistry has led to advancements that could potentially improve therapeutic outcomes for various medical conditions.

Collaborations

Throughout his career, Burgoon has collaborated with esteemed colleagues, including Ramanaiah C Kanamarlapudi and Wenxue Wu. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Hugh Alfred Burgoon, Jr. exemplifies the spirit of innovation in the pharmaceutical industry through his extensive patent portfolio and collaborative efforts. His contributions are paving the way for future advancements in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…